#23 - Tom Dayspring, M.D., FACP, FNLA – Part IV of V: Statins, ezetimibe, PCSK9 inhibitors, niacin, cholesterol and the brain
The Peter Attia Drive
00:00
Do You Have a Primary Endpoint?
In a clinical trial world, if you go down to the fda and you just put a drug through a clinical trial, youd better be empowered. In all the arms ot ose trials, that's what they were looking back at. Ten all case mortality, or corney mortals. A'll cose mortality. I don't know. It was like me telling you an et aoric senosis trial,. But hey, zeddy, it reduced my cartal infarctions, but it didn't reduce a yor ft. Fairness.
Transcript
Play full episode
